QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 deal-dispatch-from-four-roses-bourbon-to-quantum-stakes-here-are-this-weeks-sector-shake-ups

Four Roses, Six Flags, and Trump's potential Quantum investments: This week's deal activity involves big bets across va...

 leerink-partners-downgrades-avadel-pharmaceuticals-to-market-perform-announces-185-price-target

Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Outperform to Market Perform and ...

 hc-wainwright--co-downgrades-avadel-pharmaceuticals-to-neutral-lowers-price-target-to-20

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Neutral and l...

 alkermes-strikes-21-billion-avadel-deal-gains-access-to-narcolepsy-drug-lumryz

Alkermes agrees to acquire Avadel for $2.1 billion, adding the successful Lumryz drug and accelerating entry into sleep medicin...

 jefferies-downgrades-avadel-pharmaceuticals-to-hold-lowers-price-target-to-20

Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold and lowers the price target f...

 needham-downgrades-avadel-pharmaceuticals-to-hold

Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold.

Core News & Articles

Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, tod...

Core News & Articles

As previously disclosed, on May 12, 2021, Jazz Pharmaceuticals, Inc. ("Jazz") filed a formal complaint initiating a law...

 hc-wainwright--co-maintains-buy-on-avadel-pharmaceuticals-raises-price-target-to-36

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Buy and raises the ...

 wells-fargo-initiates-coverage-on-avadel-pharmaceuticals-with-equal-weight-rating-announces-price-target-of-16

Wells Fargo analyst Benjamin Burnett initiates coverage on Avadel Pharmaceuticals (NASDAQ:AVDL) with a Equal-Weight rating a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION